NGM NGM Biopharmaceuticals Inc

-0.07 (-6.25%)
Sep 22 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Company Name Stock Ticker Symbol Market Type
NGM Biopharmaceuticals Inc NGM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.07 -6.25% 1.05 16:54:47
Open Price Low Price High Price Close Price Prev Close
1.13 1.01 1.17 1.05 1.12
more quote information »

Recent News

Date Time Source Heading
9/18/202317:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/11/202316:01EDGAR2Form 8-K/A - Current report: [Amend]
8/11/202316:08EDGAR2Form 8-K - Current report
8/07/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
8/04/202317:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/04/202316:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
8/03/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202316:07EDGAR2Form 8-K - Current report
8/03/202316:01GLOBENGM Bio Reports Second Quarter 2023 Financial Results and..
5/25/202309:00GLOBENGM Bio to Participate in Upcoming Investor Conferences
5/08/202316:05GLOBENGM Bio Announces Presentation of Data from Phase 2..
5/04/202316:05GLOBENGM Bio Reports First Quarter 2023 Financial Results and..
3/01/202309:00GLOBENGM Bio to Participate in the Cowen 43rd Annual Health Care..
2/28/202316:05GLOBENGM Bio Provides Business Highlights and Reports Fourth..
1/12/202308:00GLOBENGM Bio to Participate in the B. Riley Securities 3rd Annual..
1/09/202309:00GLOBENGM Bio Outlines Corporate Strategy and Provides Guidance on..
12/12/202219:00GLOBENGM Bio Gives Presentation Featuring Preclinical..
12/09/202210:10TRMNAnalysts Are Bullish on These Healthcare Stocks: NGM..
12/07/202218:45GLOBENGM Bio Presents Preliminary Data from Phase 1 Monotherapy..
11/07/202208:00GLOBENGM Bio Announces Poster Presentation Featuring Initial..
11/04/202208:00GLOBENGM Bio Announces Poster Presentation Featuring Preclinical..
11/03/202216:05GLOBENGM Bio Provides Business Highlights and Reports Third..
11/03/202213:00GLOBENGM Bio Announces Presentation of Post-Hoc Analyses from..
10/17/202216:35TRMNNGM Biopharmaceuticals (NGM) was downgraded to a Hold Rating..
10/17/202210:38TRMNNGM Bio Tanks after NGM621 Fails in Phase 2 Study
10/17/202207:30GLOBENGM Bio Announces Topline Results from the CATALINA Phase 2..
10/16/202216:30GLOBENGM Bio to Host Conference Call to Discuss Topline Results..